Alexion Pharmaceuticals, Inc. (ALXN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)

An SI Board Since October 1997

Posts	SubjectMarks	Bans	Symbol
824	29	0	ALXN

Emcee: Larry Liebman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
524	Alexion Completes Enrollment of its Eculizumab Phase III SHEPHERD Trial in PNH P	Icebrg	-	9/21/2005
523	Bell confirms cabg-2 top-line results 4Q05 at Bear Stearns (for those watching o	keokalani'nui	-	9/13/2005
522	Alexion Pharma files $250 mln mixed shelf Fri Sep 2, 2005 4:18 PM ET WASHINGTON	Icebrg	-	9/3/2005
521	Alexion Pharmaceuticals (ALXN) and Procter & Gamble (PG) complete enrollment	kenhott	-	8/9/2005
520	Insider transaction. Bell exercise 5000 options @ USD 10 and sells them all at	Icebrg	-	8/3/2005
519	The stock closed at a 5-year high today. The last time it was here about (i.e. 2	Icebrg	-	8/2/2005
518	As VP, Barry Luke is an officer but way down on the totem pole. Indeed, alxn br	keokalani'nui	-	7/18/2005
517	Insider transaction. Barry P Luke exercised 15.000 shares @ 10 USD and sold all	Icebrg	-	7/18/2005
516	another article..Alexion towards bottom. Wall Street Transcript FDA Development	LJM	-	6/28/2005
515	Alexion Reports Results of Eculizumab Extension Trial in PNH in the Journal Bloo	LJM	-	6/28/2005
514	>>CHESHIRE, Conn., June 28 /PRNewswire-FirstCall/ -- A study showing that	tuck	-	6/28/2005
513	Thanks a lot. I actually feel better than I did before I left. Erik	Icebrg	-	6/24/2005
512	Welcome back, Erik. Hope your trip went well and that you're not suffering a	tuck	-	6/24/2005
511	Attacking the Complement System 6/17/05 Researchers at Alexion Pharmaceuticals	Icebrg	-	6/24/2005
510	<i>the only chart that I take comfort in is a 6-month flat-line following	tom pope	-	5/19/2005
509	In the biotech junior universe, the only chart that I take comfort in is a 6-mon	keokalani'nui	-	5/18/2005
508	Peter's not around, I hope, but ALXN is a good example why you should always	tom pope	-	5/17/2005
507	From Y! Thanks david193 Bank of America conference report by: david193 05/17/	keokalani'nui	-	5/17/2005
506	[Role of C5 in the development of airway inflammation, airway hyperresponsivenes	tuck	-	5/15/2005
505	I have my doubts but don't mind getting some attention over it. Interfering	keokalani'nui	-	5/12/2005
504	You beat me cuz I was looking in JCI. Despite what the PR says, I cannot find t	tuck	-	5/12/2005
503	Yale, Brigham and Women's Hospital, and Alexion Report Potential New Treatme	Icebrg	-	5/12/2005
502	Why Did the Anti-C5 Complement Antibody Pexelizumab Not Reduce Infarct Size but	Icebrg	-	5/12/2005
501	The company has done a lot of work in transplantation and complement, but by try	keokalani'nui	-	5/10/2005
500	That looks very interesting. Does this represent a new idea or is it something t	Icebrg	-	5/10/2005

Go to reply# or date (mm/dd/yy):